Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Ron H.N. van Schaik"'
Autor:
Nico van Walree, Bruno H. Stricker, Sabine Visser, Ron H.N. van Schaik, Nadine van Donk, Robin Cornelissen, Stijn L.W. Koolen, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Cor van der Leest
Publikováno v:
Thorax
Thorax, 76(11), 1150-1153. BMJ Publishing Group
Thorax, 76(11), 1150-1153. BMJ Publishing Group
Patients with advanced non-small-cell lung cancer who are treated with pemetrexed display a wide variation in clinical response and toxicity. In this prospective, multicentre cohort study, we investigated the association with treatment effectiveness
Autor:
Hassan El Bouazzaoui, T.L.Th.A. Jansen, Sakir Akin, Erik J van Helden, Vincent van Driel, Remon Baak, Ronne A T A Mairuhu, Ingrid M. Garrelds, Koen Verdonk, Jan Kees van Rooden, Evert de Jonge, Iwan A. Meynaar, Kadir Caliskan, Johannes F A B Duynstee, Paula Schriek, Jeroen Ludikhuize, Ron H.N. van Schaik, Cees van Nieuwkoop, Rugina I. Neuman, A.H. Jan Danser, Loes E. Visser, Marjan Veuger, Lettie van den Berg
Publikováno v:
Journal of Hypertension, 40(3), 606-614. Lippincott Williams & Wilkins
Background The severity of COVID-19 after SARS-CoV-2 infection is unpredictable. Angiotensin-converting enzyme-2 (ACE2) is the receptor responsible for coronavirus binding, while subsequent cell entry relies on priming by the serine protease TMPRSS2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d366b02e15b6349af19963c5c2b1b3c7
https://pure.eur.nl/en/publications/3da63918-d30a-41a0-a1cc-51d970d63c3a
https://pure.eur.nl/en/publications/3da63918-d30a-41a0-a1cc-51d970d63c3a
Autor:
Dennis A. Hesselink, Louise M. Andrews, Marian C. Clahsen-van Groningen, Brenda C. M. de Winter, Teun van Gelder, Jacqueline van de Wetering, Bronno van der Holt, Ron H.N. van Schaik, Marith I. Francke, Hoang Lan Le
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 110(1), 169-178. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110(1), 169-178. WILEY
Clinical Pharmacology and Therapeutics, 110(1), 169-178. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110(1), 169-178. WILEY
Bodyweight-based tacrolimus dosing followed by therapeutic drug monitoring is standard clinical care after renal transplantation. However, after transplantation, a meager 38% of patients are on target at first steady-state and it can take up to 3 wee
Autor:
Anton J. Oude Ophuis, Victor J. van den Berg, Imo E. Hoefer, Victor A. Umans, Pim van der Harst, Harry J.G.M. Crijns, Milos Brankovic, Bas L.J.H. Kietselaer, R.M. Oemrawsingh, K. Martijn Akkerhuis, Folkert W. Asselbergs, Ron H.N. van Schaik, Isabella Kardys, Timo Lenderink, Eric Boersma
Publikováno v:
Clinical chemistry and laboratory medicine, 58(12), 2099-2106. Walter de Gruyter GmbH
Clinical Chemistry and Laboratory Medicine, 58(12), 2099-2106. De Gruyter
Clinical Chemistry and Laboratory Medicine, 58(12), 2099-2106. Walter de Gruyter GmbH
Clinical Chemistry and Laboratory Medicine, 58(12), 2099-2106. De Gruyter
Clinical Chemistry and Laboratory Medicine, 58(12), 2099-2106. Walter de Gruyter GmbH
Objectives Details of the biological variability of high-sensitivity C-reactive protein (hs-CRP), N-terminal prohormone of brain natriuretic peptide (NT-proBNP) and ST2 are currently lacking in patients with acute coronary syndrome (ACS) but are cruc
Autor:
Brenda C. M. de Winter, Dennis A. Hesselink, Yi Li, Ron H.N. van Schaik, Lin Yang, Birgit C. P. Koch, Marith I. Francke, Teun van Gelder, Carla C. Baan, Lucia E.A. de Wit
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
Aims: Tacrolimus is a critical dose drug and to avoid under- and overexposure, therapeutic drug monitoring is standard practice. However, rejection and drug-related toxicity occur despite whole-blood tacrolimus pre-dose concentrations ([Tac]blood) be
Autor:
Ewout J. Hoorn, Teun van Gelder, Anna C. van der Burgh, Dennis A. Hesselink, Arthur D. Moes, Ron H.N. van Schaik, Robert Zietse, Brenda C.T. Kieboom
Publikováno v:
Nephrology Dialysis Transplantation, 35(1), 176-183. Oxford University Press
Background Retrospective studies suggest that tacrolimus-induced hypomagnesaemia is a risk factor for post-transplant diabetes mellitus (PTDM), but prospective studies are lacking. Methods This was a prospective study with measurements of serum magne
Autor:
Nienke J de Boer-Veger, Roos van Westrhenen, Bianca Soree, Anne-Marie Buunk, Marga Nijenhuis, Hans Mulder, Henk-Jan Guchelaar, Vera H.M. Deneer, Gerard A. Rongen, Jesse J. Swen, Bob Wilffert, Jurriaan M. J. L. Brouwer, Ron H.N. van Schaik, Jan van der Weide, Elisa J. F. Houwink
Publikováno v:
European Journal of Human Genetics, 30, 10, pp. 1114-1120
European Journal of Human Genetics, 30, 1114-1120
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30. Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120. Nature Publishing Group
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30. Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120. Nature Publishing Group
European Journal of Human Genetics, 30(10). Nature Publishing Group
Contains fulltext : 286842.pdf (Publisher’s version ) (Closed access) The Dutch Pharmacogenetics Working Group (DPWG) guideline presented here, presents the gene-drug interaction between the genes CYP2C19 and CYP2D6 and antidepressants of the selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565c0a685f5e344ceb85fd0fd0e5746c
https://hdl.handle.net/1887/3247348
https://hdl.handle.net/1887/3247348
Autor:
Nienke J de Boer-Veger, Vera H.M. Deneer, Ron H.N. van Schaik, Gerard A. Rongen, Jan van der Weide, Henk-Jan Guchelaar, Bob Wilffert, Bianca Soree, Marga Nijenhuis, Hans Mulder, Elisa J. F. Houwink, Maja Matic, Jesse J. Swen, Anne-Marie Buunk
Publikováno v:
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1105-1113
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics, 30, 10, pp. 1105-1113
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1105-1113
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics, 30, 10, pp. 1105-1113
Contains fulltext : 286843.pdf (Publisher’s version ) (Closed access) The current Dutch Pharmacogenetics Working Group (DPWG) guideline, describes the gene-drug interaction between CYP2D6 and the opioids codeine, tramadol and oxycodone. CYP2D6 geno
Autor:
Christopher J. Logothetis, Manolis Kogevinas, Piet Ost, Jong Y. Park, Minh-Phuong Huynh-Le, Johanna Schleutker, Jose E. Castelao, Apcb, Stella Koutros, Canary Pass Investigators, Rosalind A. Eeles, Robin J. Leach, David E. Neal, Janet L. Stanford, Ana Vega, Roshan Karunamuni, Radka Kaneva, Olivier Cussenot, Azad Hassan Abdul Razack, Anders M. Dale, Gyorgy Petrovics, Wei Zheng, Sue A. Ingles, William J. Blot, Esther M. John, Chun Chieh Fan, Ruth C. Travis, Lorelei A. Mucci, Robert J. Hamilton, Wesley K. Thompson, Luc Multigner, Demetrius Albanes, Artitaya Lophatananon, Fredrik Wiklund, Marie-Élise Parent, Christopher A. Haiman, Frank Claessens, Florence Menegaux, Susan L. Neuhausen, Alicja Wolk, Maria Elena Martinez, Kathryn L. Penney, Catherine M. Tangen, Tyler M. Seibert, Jennifer J. Hu, Hermann Brenner, Sune F. Nielsen, Jyotsna Batra, Marija Gamulin, Ian G. Mills, Nc-La PCaP Investigators, Christiane Maier, Barry S. Rosenstein, Stephen Watya, Aswin George Abraham, Manuel R. Teixeira, Lui Asona, Yong-Jie Lu, Kim De Ruyck, Paul A Townsend, Sonja I. Berndt, Eli Marie Grindedal, Ole A. Andreassen, Catharine M L West, Ron H.N. van Schaik, Zsofia Kote-Jarai, Lisa F. Newcomb, Kenneth Muir, Børge G. Nordestgaard, Karina Dalsgaard Sørensen, Chad D. Huff, Jay H. Fowke, Henrik Grönberg, Dana C. Crawford, Adam S. Kibel, Robert J. MacInnis, Cezary Cybulski, Nora Pashayan
IntroductionProstate cancer risk stratification using single-nucleotide polymorphisms (SNPs) demonstrates considerable promise in men of European, Asian, and African genetic ancestries, but there is still need for increased accuracy. We evaluated whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff663c7f08f3f3c5a920a722669dc0e8
https://doi.org/10.1101/2021.08.14.21261931
https://doi.org/10.1101/2021.08.14.21261931
Autor:
Fleur van der Sijde, Leonie J. M. Mekenkamp, Quisette P. Janssen, Marjolein Y.V. Homs, Zakia Azmani, Johanna W. Wilmink, Wilfred F. J. van IJcken, Bert A. Bonsing, Saskia A C Luelmo, Bas Groot Koerkamp, Brigitte C M Haberkorn, Eveline E. Vietsch, Dana A M Mustafa, Jan Willem B. de Groot, Casper H.J. van Eijck, Marc G. Besselink, Martijn P. Lolkema, Ron H.N. van Schaik
Publikováno v:
Therapeutic advances in medical oncology, 13. SAGE Publications Inc.
Therapeutic Advances in Medical Oncology, 13, 1-14. SAGE PUBLICATIONS LTD
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, 13. SAGE Publishing
Therapeutic Advances in Medical Oncology, 13, 1-14. SAGE PUBLICATIONS LTD
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, 13. SAGE Publishing
Background:Biomarkers predicting treatment response may be used to stratify pancreatic ductal adenocarcinoma (PDAC) patients for therapy. The aim of this study was to identify circulating tumor DNA (ctDNA) mutations that associate with tumor progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef1aea0e11d599bac06eea43400b053
https://doi.org/10.1177/17588359211033704
https://doi.org/10.1177/17588359211033704